Prudential Financial
ALLO icon

Prudential Financial’s Allogene Therapeutics ALLO Stock Holding History

Prudential Financial’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61K Buy
+25,000
New +$50.1K ﹤0.01% 2288
2025
Q4 		– Sell
-15,930
Closed -$19.8K – 2219
2025
Q3 		$19.8K Hold
15,930
– – ﹤0.01% 2401
2025
Q2 		$18K Buy
15,930
+4,045
+34% +$5.38K ﹤0.01% 2408
2025
Q1 		$17.4K Buy
+11,885
New +$22.4K ﹤0.01% 2260
2024
Q4 		– Sell
-214,495
Closed -$601K – 2289
2024
Q3 		$601K Sell
214,495
-17,401
-8% -$46.4K ﹤0.01% 2136
2024
Q2 		$540K Buy
231,896
+33,484
+17% +$98.8K ﹤0.01% 2152
2024
Q1 		$887K Sell
198,412
-180,428
-48% -$753K ﹤0.01% 1907
2023
Q4 		$1.22M Buy
+378,840
New +$1.07M ﹤0.01% 1721
2023
Q3 		– Sell
-33,890
Closed -$168K – 2595
2023
Q2 		$168K Sell
33,890
-54,541
-62% -$295K ﹤0.01% 2450
2023
Q1 		$437K Buy
+88,431
New +$567K ﹤0.01% 2133
2021
Q1 		– Sell
-102,036
Closed -$2.58M – 2489
2020
Q4 		$2.58M Sell
102,036
-162,346
-61% -$5.29M ﹤0.01% 1305
2020
Q3 		$9.97M Buy
264,382
+248,237
+1,538% +$9.36M 0.02% 655
2020
Q2 		$692K Buy
+16,145
New +$584K ﹤0.01% 1801

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prudential Financial's ALLO Position: Q1 2026 in Review

Prudential Financial opened a new position in Allogene Therapeutics (ALLO) in Q1 2026: 25,000 shares worth $61K. The stake represents ﹤0.01% of the portfolio and ranks #2288 among its holdings. This is a return to the name: Prudential Financial previously reported a position in ALLO as recently as Q3 2025.

Prudential Financial first reported a position in ALLO in Q2 2020 and has held it in 13 quarters since. The position peaked at $9.97M in Q3 2020. 208 funds tracked by Wall St. Rank hold ALLO as of Q1 2026.

  • Prudential Financial held 25,000 shares of Allogene Therapeutics worth $61K as of Q1 2026.
  • Allogene Therapeutics was a new Prudential Financial position in Q1 2026.
  • Allogene Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2288 holding.
  • Prudential Financial first reported a position in Allogene Therapeutics in Q2 2020 and has held it in 13 quarters since.
  • Prudential Financial's Allogene Therapeutics position peaked at $9.97M in Q3 2020.
  • 208 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.